Winters can be uncomfortable for many people, but they can prove life-threatening for those with hypertension if they don't ...

A new treatment option for patients with uncontrollable high blood pressure is now available at Willis Knighton Health. ...

AZD-3427 is commercialized by AstraZeneca, with a leading Phase II program in Congestive Heart Failure (Heart Failure).

Researchers suggest an application to FDA may be made within the next 12 months, requesting approval to carry out a human clinical trial with the gene therapy.

Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute ...

Oral oestrogen-progestin therapy was linked with an increased risk of heart disease and venous thromboembolism, a condition where blood clots form in veins. Conversely, tibolone medications were ...

Diastolic heart failure, which is when the ventricles cannot relax ... 117.031855 National Heart, Lung, and Blood Institute. Heart failure: treatment. Meyer TE. Primary pharmacologic therapy for heart ...

Prescription medications are first-line treatment options for congestive heart failure, meaning they're typically tried before any surgeries or other procedures. Medications are not a cure ...

Heart failure with preserved ejection fraction (HFpEF ... and relaxation impairment associated with pulmonary hypertension. Hyperglycemia accelerated diastolic dysfunction and HFpEF onset associated ...

New Delhi: The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications that treat ...

New Delhi, Nov 27 (IANS) The failure of the trial of the drug AZD4041 by pharma giant AstraZeneca, to combat opioid use disorder (OUD), highlights the challenges in developing non-opioid medications ...